January 2005
Taber's Cyclopedic Medical Dictionary;2005, p1749
Reference Entry
A definition of the term "pravastatin" is presented. It refers to an HMGCoA reductase inhibitor and lipid-lowering agent, which is administered orally as an adjunct to diet and exercise to manage hypercholesterolemia and mixed dyslipidemias.


Related Articles

  • Rosuvastatin reigns supreme for hypercholesterolaemia.  // PharmacoEconomics & Outcomes News;11/3/2007, Issue 540, p5 

    The article focuses on a study on the cost effectiveness of rosuvastatin for the treatment of hypercholesterolaemia in Canada. It states that the cost effectiveness of rosuvastatin against atorvastatin, pravastatin and simvastatin among patients with hypercholesterolaemia was evaluated. It cites...

  • endostatin.  // Taber's Cyclopedic Medical Dictionary;2005, p707 

    A definition of the medical term "endostatin" is presented. Endostatin refers to the protein fragment of collagen that contributes to the regulation of blood vessel growth. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co. The pronunciation of the...

  • National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool. Ramli, Azuana; Aljunid, Syed Mohamed; Sulong, Saperi; Md Yusof, Faridah Aryani // Therapeutics & Clinical Risk Management;2013, Vol. 9, p491 

    Purpose: HMG-CoA reductase inhibitors (statins) are extensively used in treating hypercholesterolemia. The statins available in Malaysia include atorvastatin, lovastatin, pravastatin, rosuvastatin, simvastatin, and fluvastatin. Over the years, they have accumulated in the National Drug...

  • Doubts over statins. Ferriday, Charlotte // Pulse;Jul2013, p30 

    A letter to the editor is presented in response to the investigative article entitled "Is primary prevention with statins worth the effort?" that was published in the previous issue.

  • Perspectives on the Cardioprotective Effects of Statins. Jian-Dong Luo; Chen, Alex F. // Current Medicinal Chemistry;Aug2003, Vol. 10 Issue 16, p1593 

    Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase), the rate-limiting enzyme of cholesterol synthesis. In recent years, statins have become the major choice of treatment for hypercholesterolemia. Emerging evidence from both animal and human studies...

  • statins.  // Taber's Cyclopedic Medical Dictionary;2005, p2066 

    The article presents a definition of the term "statins." It refers to a drug having powerful lipid-lowering properties belonging to the class 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors.

  • Double-Blind Comparison of Apolipoprotein and Lipoprotein Particle Lowering Effects of Atorvastatin and Pravastatin Monotherapy in Patients With Primary Hypercholesterolemia. Dallongeville, Jean; Fruchart, Jean-Charles; Maigret, Pascal; Bertolini, Stefano; Bon, Gabriele Bittolo; Campbell, M. Malcom; Farnier, Michel; Langan, John; Mahla, Gerhard; Pauciullo, Paolo; Sirtori, Cesare // Journal of Cardiovascular Pharmacology & Therapeutics;Jun1998, Vol. 3 Issue 2, p103 

    The article presents a study to determine the effects of atorvastatin and pravastatin in lowering apolipoprotein and lipoprotein in patients with primary hypercholesterolemia. The study shows that both atorvastatin and pravastatin increased apoA-I levels, but atorvastatin appears to efficiently...

  • Effect of Statin Therapy on Arterial Stiffness in Patients with Hyperlipidemia: Shiga Pravastatin Atherosclerosis Study (SHIPAS) Group. Matsuo, Shinro; Nakamura, Yasuyuki; Yamada, Tetsuhiro; Uchida, Yasukazu; Nakae, Ichiro; Horie, Minoru // Journal of Applied Research;2005, Vol. 5 Issue 2, p397 

    A man is as old as his arteries and the vascular remodeling is a common problem in the elderly. Aortic pulse wave velocity (PWV) provides noninvasive measurement of the mechanical properties of arteries. Objective: We measured the effects of HMA-CoA inhibitor (pravastatin) on arterial stiffness,...

  • Amiodarone Interacts with Simvastatin but not with Pravastatin Disposition Kinetics. Becquemont, L.; Neuvonen, M.; Verstuyft, C.; Jaillon, P.; Letierce, A.; Neuvonen, P. J.; Funck-Brentano, C. // Clinical Pharmacology & Therapeutics;May2007, Vol. 81 Issue 5, p679 

    The aim of this study was to determine the influence of amiodarone on the pharmacokinetics of simvastatin and pravastatin in humans. This was a prospective, crossover, randomized, open-label study performed in 12 healthy volunteers comparing the pharmacokinetics of a single oral dose of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics